Outsourced Pharma White Papers

  1. Turning Oncolytic Viruses Into Manufacturable Cancer Therapies 10/21/2026

    Oncolytic virus manufacturing depends on preserving infectivity and potency. Materials, hold times, and product-specific analytics shape scalability well before GMP production.

  2. Choosing A CDMO That Can Grow With A Viral Program 10/21/2026

    Viral modalities demand more from CDMO selection: relevant experience, rigorous tech transfer, analytical readiness, and a clear path to scale matter more than equipment alone.

  3. Connected By Design: Laboratory Automation And Digital Transformation Strategy 10/19/2026

    Task-level automation delivers isolated gains, but the larger payoff in GxP laboratories comes from connecting instruments, systems, and data into workflows where samples move with minimal human handoffs.

  4. Cell Counting Method: Cell Type, Precision, And Accuracy For Process Development 10/16/2026

    Accuracy and precision in cell count and viability depend on cell type, morphology, and matrix. Comparing automated and manual methods across three therapy-relevant cell types shows why no single method fits all.

  5. The Early Advantage For IND Success And Beyond 10/16/2026

    Manufacturing decisions made while assembling an IND package shape later cGMP operations and commercial viability. Modality-specific bench-to-IND pathways aim to move programs toward the clinic with fewer downstream surprises.

  6. How To Prepare For Risk-based Biological Reactivity Testing 10/16/2026

    Biological reactivity testing is moving from material classification toward risk-based evaluation, where chemistry data, exposure, and application determine what evidence is enough for each material.

  7. Eliminate Variability, Accelerate Results: Value Of Ready-To-Use Reagents 10/15/2026

    Pre-made solutions reduce operator variability, save bench time, and lower contamination risk by eliminating reagent preparation and reducing handling.

  8. Is Your Water Undermining Your Results? 10/15/2026

    Water is often chosen by availability rather than application. Defining it as a controlled process parameter targets a variability source that routinely escapes root cause analysis.

  9. Why Reagent Quality Defines Research Success 10/15/2026

    Water grade, buffer preparation, and packaging each shape whether sensitive assays hold up. Reagent selection hinges on matching purity to application sensitivity, regulatory standards, and tolerance for contamination risk.

  10. Single-use Mixing Systems For Protein Products: Dissolution And Mechanical Stress 10/14/2026

    Mixer design and fill volume shape both how well a solution homogenizes and how much mechanical stress a protein experiences. Impeller configurations are compared against a conventional stirrer.